India Tetanus Toxoid Vaccine Market Size & Outlook
Related Markets
India tetanus toxoid vaccine market highlights
- The India tetanus toxoid vaccine market generated a revenue of USD 148.0 million in 2024 and is expected to reach USD 224.0 million by 2030.
- The India market is expected to grow at a CAGR of 7.2% from 2025 to 2030.
- In terms of segment, diphtheria,tetanus, and pertussis (dtap) was the largest revenue generating vaccine in 2024.
- Diphtheria and Tetanus (DT) is the most lucrative vaccine segment registering the fastest growth during the forecast period.
Tetanus toxoid vaccine market data book summary
| Market revenue in 2024 | USD 148.0 million |
| Market revenue in 2030 | USD 224.0 million |
| Growth rate | 7.2% (CAGR from 2025 to 2030) |
| Largest segment | Diphtheria,tetanus, and pertussis (dtap) |
| Fastest growing segment | Diphtheria and Tetanus (DT) |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diphtheria,Tetanus, and Pertussis (DTaP), Diphtheria and Tetanus (DT) |
Other key industry trends
- In terms of revenue, India accounted for 2.5% of the global tetanus toxoid vaccine market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan tetanus toxoid vaccine market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 384.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Tetanus Toxoid Vaccine Market Scope
Tetanus Toxoid Vaccine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Grifols, S.A. | View profile | - | - | - |
| Merck & Co., Inc. | View profile | - | - | - |
| Pfizer Inc. | View profile | - | - | - |
| Abbott | View profile | - | - | - |
| Emergent BioSolutions Inc | View profile | 1600 | 300 Professional Drive, Gaithersburg, MD, United States, 20879 | https://www.emergentbiosolutions.com |
| CEVA Inc | View profile | 424 | 15245 Shady Grove Road, Suite 400, Rockville, MD, United States, 20850 | https://www.ceva-dsp.com |
| Virbac SA | View profile | 5400 | 2065m LID, 1 ere avenue, Carros, France, 06516 | https://www.virbac.com |
| Zoetis Inc Class A | View profile | 14100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | https://www.zoetis.com |
| GSK PLC ADR | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
India tetanus toxoid vaccine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tetanus toxoid vaccine market will help companies and investors design strategic landscapes.
Diphtheria,tetanus, and pertussis (dtap) was the largest segment with a revenue share of 65.27% in 2024. Horizon Databook has segmented the India tetanus toxoid vaccine market based on diphtheria,tetanus, and pertussis (dtap), diphtheria and tetanus (dt) covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to India tetanus toxoid vaccine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of India tetanus toxoid vaccine market databook
-
Our clientele includes a mix of tetanus toxoid vaccine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India tetanus toxoid vaccine market , including forecasts for subscribers. This country databook contains high-level insights into India tetanus toxoid vaccine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
India End Use - Tetanus Toxoid Vaccine Market size, 2024 - 2030 (US$M)
India Tetanus Toxoid Vaccine Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
